If a pill which alleviated the worst aspects of ageing was available, would you take it? As strange as it may seem, living to 150 could soon be a reality thanks to the development of anti-ageing drugs.
Rapamycin is currently licensed to treat cancer, but it has had surprising results in the battle against ageing. A team from the Institute of Ageing at University College London has found that when mice were fed the drug, they lived longer. The drug also offered protection against neurodegenerative conditions which are linked to ageing.
The drug works by inhibiting a powerful molecule in the nutrient sensing network, which has a positive effect on insulin, amino acids and cellular energy. If the positive effects of this drug could be harnessed, then the incidence of heart and kidney disease would decrease and recipients of the drug would have better immune systems and retain cognitive power for longer.
To find out more about how rapamycin could delay the ageing process, read A double whammy for aging?.